Determination of the factor V Leiden (G1691A) and prothrombin (G20210A) mutations by using a dHPLC system.

被引：0
|
作者：
van Heerde, WL
Kenis, H
Lux, P
Hamulyak, K
Wi, D
Lavergne, JMLS
Reutelingsperger, CPM
机构：
[1] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[2] INSERM, U143, Paris, France
[3] Univ Hosp Maastricht, Dept Haematol, Maastricht, Netherlands
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
1337
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [21] Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among healthy population from western Iran
    Rahimi, Z.
    Mozafari, H.
    Vaisiraygani, A.
    Nagel, R. I.
    Muniz, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 446 - 447
  • [22] Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran
    Rahimi, Zohreh
    Vaisi-Raygani, Asad
    Mozafari, Hadi
    Kharrazi, Hadi
    Rezaei, Mansour
    Nagel, Ronald L.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 25 (03) : 280 - 283
  • [23] Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population
    Angchaisuksiri, P
    Pingsuthiwong, S
    Aryuchai, K
    Busabaratana, M
    Sura, T
    Atichartakarn, V
    Sritara, P
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 65 (02) : 119 - 122
  • [24] Hypercoagulability markers in young asymptomatic heterozygous carriers of factor V Leiden (G1691A) or prothrombin (G20210A) variant
    Godoi, LC
    Fernandes, AP
    Vieira, LM
    Melgaço, DA
    de Bastos, M
    Ribeiro, MD
    Carvalho, MD
    Dusse, LMSA
    CLINICA CHIMICA ACTA, 2006, 365 (1-2) : 304 - 309
  • [25] Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran
    Zohreh Rahimi
    Asad Vaisi-Raygani
    Hadi Mozafari
    Hadi Kharrazi
    Mansour Rezaei
    Ronald L. Nagel
    Journal of Thrombosis and Thrombolysis, 2008, 25 : 280 - 283
  • [26] Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction
    Forte, Giusi Irma
    Vaccarino, Loredana
    Palmeri, Marisa
    Branzi, Angelo
    Caldarera, Claudio M.
    Scola, Letizia
    Caruso, Calogero
    Licastro, Federico
    Lio, Domenico
    BIOGERONTOLOGY, 2011, 12 (05) : 485 - 490
  • [27] Factor V G1691A and prothrombin G20210A in idiopathic venous thrombosis in childhood and adolescence
    Schobess, R
    Junker, R
    Auberger, K
    Münchow, N
    Nowak-Göttl, U
    THROMBOSIS AND HAEMOSTASIS, 1999, : 255 - 255
  • [28] Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus
    Wakim-Ghorayeb, SF
    Keleshian, SH
    Timson, G
    Finan, RR
    Najm, P
    Irani-Hakime, N
    Almawi, WY
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (01) : 84 - 86
  • [29] Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency
    Hézard, N
    Bouaziz-Borgi, L
    Remy, MG
    Nguyen, P
    CLINICAL CHEMISTRY, 2006, 52 (04) : 665 - 670
  • [30] The G1691A Mutation of the Factor V Gene (Factor V Leiden) and the G20210A Mutation of the Prothrombin Gene as Risk Factors in Thrombotic Microangiopathies
    Sucker, Christoph
    Kurschat, Christine
    Hetzel, Gerd R.
    Grabensee, Bernd
    Maruhn-Debowski, Beate
    Loncar, Robert
    Ostojic, Ljerka
    Scharf, Ruediger E.
    Zotz, Rainer B.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (03) : 360 - 363
12345